The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry

M. Meegdes, S.M.E. Geurts, F.L.G. Erdkamp, M.W. Dercksen, B.E.P.J. Vriens, K.N.A. Aaldering, M.J.A.E. Pepels, L.M.H. Winkel, N.J.A. Teeuwen, M. Boer, V.C.G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry